G 224 (Lithium Carbonate Extended Release 450 mg)
Pill with imprint G 224 is Yellow, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Glenmark Generics Inc..
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; schizoaffective disorder; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 224
Lithium Carbonate Extended Release
- Imprint:
- G 224
- Strength:
- 450 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Glenmark Generics Inc.
- Inactive Ingredients:
- sodium alginate
microcrystalline cellulose
ferric oxide yellow
isopropyl alcohol
magnesium silicate
magnesium stearate
sodium starch glycolate type A potato
hypromelloses
Note: Inactive ingredients may vary.
More about lithium
- Lithium Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 280 Reviews
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Lithium
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Capsules and Tablets
- Lithium Syrup and Oral Solution
- Lithium (Advanced Reading)
Other brands: Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
